Wyniki wyszukiwania - Biblioteka Nauki

1

Quality of life of patients with atrial fibrillation

100%

Ślifirczyk A. , Michalczuk T. , Piszcz P. , Kierczuk E. , Kowalenko M. , Zalewski R. , Krajewska-Kułak E.

Progress in Health Sciences

|

2018

|

tom 8(1)

88-92

EN

Introduction: Atrial fibrillation (AF) is one of the most frequent arrhythmias. In Poland, there is a risk of developing AF in about 400,000 people. Atrial fibrillation occurs most frequently as a result of disorders of physiological automatism and afterdepolarization and triggered activity. The treatment strategy of AF is based on pharmacological treatment and procedures such as ablation or cardioversion. The quality of life as defined by the WHO is an individual perception of one's well-being. On the other hand, the assessment of the quality of life in illness is modified regarding health problems. Purpose: The main goal of the study was to get to know the quality of life of people with atrial fibrillation. Materials and methods: The research was carried out using a diagnostic survey, based on a survey among 100 patients diagnosed with AF. The place of the research was the Regional Specialist Hospital in Biała Podlaska, in the Emergency Department. Results: Increased morbidity was observed among women and people over the age of 60. The majority of patients with AF declared the quality of life at the medium level. The respondents most often followed medical recommendations. The majority of respondents did not follow healthy lifestyle rules, because as many as 68% of respondents did not do any physical activity and a significant part of the respondents smoked cigarettes and had an inflated BMI. Conclusion: AF affects the quality life by causing sadness, irritation and insomnia.

2

Comparative analysis of pharmacotherapy used by Emergency Medical Services in Poland.

88%

Trochimiak P. , Leszczyński P. K. , Świniarski P.

Critical Care Innovations

|

2020

|

tom 3

|

nr 3

20-30

EN

INTRODUCTION: Pharmacotherapy is essential during emergency medical services (EMS). Medication administered in pre-hospital conditions enables i.a.: sedation, analgesia, treatment of arrhythmias, and resuscitation. The equipment of the paramedic’s box (Drug Kit) in an ambulance depends on the Rescue System in a given country. In Poland, since several years, there has been a standardized list of medications available in the emergency medical services. The authors attempt to assess the indication of pharmaceuticals that are most commonly used and those that may turn out to be unnecessary in pre-hospital care. MATERIAL AND METHODS: The interventions of two emergency medical teams (specialized "SEMS" and basic "BEMS") from 2019 were analyzed. The Kolmogorov-Smirnov variable distribution normality test was used for statistical analysis; Pearson correlation and Chi squared independence tests. All results were considered significant at p <0.05. RESULTS: The teams intervened 4,530 times in the analyzed period. Medications were used in 1742 cases, which accounts for 38.45% of all interventions (BEMS - 1429; 82.03% vs. SEMS: 313; 17.97%). The most commonly administered were: Natrii chloridum 0.9%, Captoprilum, Ephinephrinum and Hydroxyzinum. Drugs such as: Flumazenilum, HES - hydroxyethyl starch, Isosorbidi mononitrans, Lidocaini hydrochloridum, Urapidilum were not administered. Comparing the total amount of drugs used between the teams, a statistically strong correlation was demonstrated (χ2 = 402.41; p = 0.000), point out more frequent use of drugs by BEMS staff. CONCLUSIONS: There is a group of drugs that are not used in the emergency medical service. The equipment of the paramedic’s box in the BEMS can be considered as sufficient because drugs from the SEMS were used occasionally. Due to the significant differences in the frequency of administration of individual drugs, a modification of the list of medicines in the emergency medical service in Poland should be considered.

PL

WSTĘP: Farmakoterapia jest niezbędna w pracy zespołów ratownictwa medycznego (EMS). Podane leki w warunkach przedszpitalnych umożliwiają m.in .: sedację, znieczulenie, leczenie arytmii i resuscytację. Wyposażenie ampularium ratownika medycznego w karetce zależy od systemu ratownictwa w danym kraju. W Polsce od od kilku lat istnieje ujednolicona lista leków dostępnych dla ratowników medycznych. Autorzy pracy podejmują próbę wskazania leków, które są najczęściej stosowane i tych, które mogą się okazać zbędne w opiece przedszpitalnej. MATERIAŁ I METODY: Przeanalizowano interwencje dwóch zespołów ratownictwa medycznego (specjalistyczny "SEMS" i podstawowy "BEMS") z 2019 roku. Do celów statystycznych zastosowano test normalności rozkładu zmiennej Kołmogorowa-Smirnowa, testy korelacji Pearsona i niezależności Chi-kwadrat. Wszystkie wyniki uznano za istotne przy p <0.05. WYNIKI: Zespoły w analizowanym okresie interweniowały 4530 razy. Leki były używane w 1742 przypadkach, co stanowi 38.45% wszystkich interwencji (BEMS - 1429; 82.03% vs. SEMS: 313; 17.97%). Najczęściej podawano: Natrii chloridum 0.9%, Captoprilum, Ephinephrinum i Hydroxyzinum. Leki takie jak: Flumazenilum, HES - hydroksyetyloskrobia, Isosorbidi mononitrans, Lidocaini hydrochloridum, Urapidilum - nie były podawane. Porównując całkowitą ilość leków narkotycznych stosowanych w zespołach, stwierdzono statystycznie silną korelację (χ2 = 402.41; p = 0.000), wskazując na ich częstsze używanie przez personel zespołów podstawowych. WNIOSKI: Istnieje grupa leków, które nie są stosowane w ratownictwie medycznym. Wyposażenie ampularium ratownika medycznego w podstawowych zespołach ratownictwa medycznego można uznać za wystarczające, ponieważ sporadycznie używano leków z ampularium zespołu specjalistycznego. Ze względu na istotne różnice w częstości podawania poszczególnych leków należy rozważyć modyfikację leków stosowanych w pogotowiu ratunkowym w Polsce.

3

Diagnosis and therapy of neuroendocrine neoplasms of the gastrointestinal tract

88%

Deptała A. , Czerw A.

Family Medicine & Primary Care Review

|

2016

|

nr 3

377-381

4

Lyme disease: etiology, pathogenesis, clinical courses, diagnostics and treatment

75%

Wasiluk A. , Zalewska-Szajda B. , Waszkiewicz N. , Kępka A. , Szajda D. , Wojewódzka-Żeleźniakowicz M. , Ładny J. , Pancewicz S. , Zwierz Z. , Zwierz K.

|

nr 2

179-186

EN

Lyme disease (LD) is caused by Borrelia burgdorferi, transferred by infected ticks Ixodus ricinus. LD occurs endemically in Europe, America and Northern regions of Asia. In Poland, LD is the most frequent tick borne disease, which causes serious epidemiological problems. The main health hazard of LD occurs on the forested areas of Podlasie, Maritime province, the West Poland lake district, and Carpathians. The highest incidence 114.0 per 100 000 was registered in Podlaskie province. The infectious cycle of Borrelia burgdorferi includes: nymph moulds to adult, eggs laid by female, eggs hatch to larva, larva feeds on first host, fully fed larva drops to ground, larva moulds to nymph, nymph attaches to and feeds on the second host. LD is a chronic disease attacking many organs, including the skin, heart, brain and joints. LD is divided into three stages based on clinical symptoms: I - limited infection (Erythema migrans and Borrelia lymphoma), II - disseminated infection (numerous erythema migrans, early neuro-borreliosis, joint inflammation, Lyme carditis), III - late borreliosis (chronic atrophic limbs infla-mmation, late neuroborreliosis, chronic joint infla-mmation). At present, the best diagnostic method for LD is a labor- and time consuming two-stage serological method. First-line antibiotics in the treatment of Lyme disease are doxycycline, amoxicillin, cefuroxime axetil, ceftriaxone, cefo-taxime, and penicillin G. The best method of avoiding Borrelia burgdorferi infection is to avoid biting from ticks carrying spirochetes. Early removal of ticks, protects against spirochaetal infection.